Studies have shown that high expression of CD4+ and CD8+ T lymphocytes in NSCLC led to the increase in the median survival and 3-year survival rates rather than low expression and no expression, whereas low expression of Foxp3+ T lymphocytes led to higher median survival and 3-year survival rates rather than high expression [28]. The gene discussed is CD4; the disease is non-small cell lung carcinoma.